0 Комментарии
0 Поделились
3Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Комментарии 0 Поделились 5Кб Просмотры 0 предпросмотр1
-
GVHD Treatment Market to Reach USD 2.1 Billion by 2031 | CAGR 8.5%According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031. Graft versus Host Disease, a serious complication following stem cell or bone...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
What Is Driving Demand in the Azacitidine Market for Cancer Treatment?Executive Summary Azacitidine Market Size and Share Across Top Segments CAGR Value The global azacitidine market was valued at USD 90.24 billion in 2024 and is expected to reach USD 165.79 billion by 2032During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.90%, primarily driven by increasing geriatric population By utilizing few steps or a number of...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр